RUBY · Categories · Form 4

RUBY - SEC Form 4 insider transactions

Rubius Therapeutics Inc. (RUBY) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for RUBY

• 1198d
  SEC Form 4: Appelhans Dannielle sold $1,323 worth of shares (10,385 units at $0.13), closing all direct ownership in the company

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1223d
  SEC Form 4: Cagnoni Pablo J sold $2,112 worth of shares (8,448 units at $0.25), decreasing direct ownership by 11% to 66,082 units to cover withholding tax

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1223d
  SEC Form 4: Appelhans Dannielle converted options into 7,500 shares and sold $970 worth of shares (3,878 units at $0.25), increasing direct ownership by 54% to 10,385 units to satisfy withholding tax

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1224d
  SEC Form 4: Cagnoni Pablo J converted options into 46,250 shares and sold $1,745 worth of shares (7,240 units at $0.24), increasing direct ownership by 110% to 74,530 units (tax withholding)

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1224d
  SEC Form 4: Turka Laurence A. converted options into 16,063 shares and sold $622 worth of shares (2,593 units at $0.24), increasing direct ownership by 274% to 18,391 units to satisfy withholding obligation

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1397d
  SEC Form 4: Appelhans Dannielle converted options into 12,500 shares and sold $4,590 worth of shares (5,737 units at $0.80) to cover taxes

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1408d
  SEC Form 4 filed by Schaffert Susanne

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1488d
  SEC Form 4 filed by Holles Natalie C.

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1488d
  SEC Form 4 filed by Prener Anne

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1488d
  SEC Form 4 filed by Symonds Jonathan

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1488d
  SEC Form 4 filed by Afeyan Noubar

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1488d
  SEC Form 4 filed by Cuss Francis M

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1488d
  SEC Form 4 filed by Rosenblatt Michael

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1488d
  SEC Form 4 filed by Sohn Catherine A.

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1488d
  SEC Form 4 filed by Epstein David R

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1509d
  SEC Form 4: Epstein David R bought $43,329 worth of shares (30,000 units at $1.44), increasing direct ownership by 0.64% to 4,720,012 units

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1588d
  SEC Form 4: Cagnoni Pablo J converted options into 21,250 shares and sold $44,236 worth of shares (6,730 units at $6.57), increasing direct ownership by 69% to 35,520 units (for withholding tax)

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1588d
  SEC Form 4 filed by Carmona Jose

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1588d
  SEC Form 4 filed by Appelhans Dannielle

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1588d
  SEC Form 4: Keson-Brookes Maiken converted options into 8,075 shares and sold $17,957 worth of shares (2,732 units at $6.57) to cover withholding tax

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1588d
  SEC Form 4: Turka Laurence A. converted options into 7,438 shares and sold $16,544 worth of shares (2,517 units at $6.57) (withholding obligation)

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1741d
  SEC Form 4 filed by Appelhans Dannielle

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1852d
  SEC Form 4 filed by Epstein David R

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1852d
  SEC Form 4 filed by Rosenblatt Michael

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1852d
  SEC Form 4 filed by Sohn Catherine A.

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1852d
  SEC Form 4 filed by AFEYAN NOUBAR

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1852d
  SEC Form 4 filed by Symonds Jonathan

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1852d
  SEC Form 4 filed by Cuss Francis M

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1852d
  SEC Form 4 filed by Holles Natalie C.

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1852d
  SEC Form 4 filed by Prener Anne

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1904d
  SEC Form 4: Llc Partner General Iv Fund Ventures Flagship bought $6,090,000 worth of Common Stock (210,000 units at $29.00)

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1911d
  SEC Form 4: Maiken Keson-Brookes exercised 25,000 units of Common Stock at a strike of $7.70 and sold $505,965 worth of Common Stock (25,000 units at $20.24)

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1938d
  SEC Form 4: R David Epstein sold $398,560 worth of Common Stock (26,704 units at $14.93), decreasing ownership by 0.57% to 4,690,012 units

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1944d
  SEC Form 4: R David Epstein sold $1,468,788 worth of Common Stock (98,737 units at $14.88), decreasing ownership by 2% to 4,716,716 units

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1952d
  SEC Form 4 filed by Maiken Keson-Brookes

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1952d
  SEC Form 4 filed by M. Christina Coughlin

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1952d
  SEC Form 4 filed by A. Laurence Turka

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)
• 1952d
  SEC Form 4 filed by J Pablo Cagnoni

  4 - Rubius Therapeutics, Inc. (0001709401) (Issuer)

Other RUBY categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends